BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22131211)

  • 1. Warts and all at last: HPV vaccination.
    Hammond P
    BMJ; 2011 Nov; 343():d7779. PubMed ID: 22131211
    [No Abstract]   [Full Text] [Related]  

  • 2. (Not) warts and all.
    Hammond P
    BMJ; 2008 Oct; 337():a2186. PubMed ID: 18948345
    [No Abstract]   [Full Text] [Related]  

  • 3. HPV vaccine strategies: the cost of HPV and the choice of vaccine.
    Morris SR
    Sex Transm Infect; 2009 Sep; 85(5):315-6. PubMed ID: 19773455
    [No Abstract]   [Full Text] [Related]  

  • 4. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL; Joura EA
    BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV vaccination's second act: promotion, competition, and compulsion.
    Schwartz JL
    Am J Public Health; 2010 Oct; 100(10):1841-4. PubMed ID: 20724671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
    PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quadrivalent HPV vaccine. Wider cost benefits of vaccine.
    O'Mahony C; Greenhouse P; Robinson A; Sonnex C
    BMJ; 2010 Aug; 341():c4455. PubMed ID: 20724414
    [No Abstract]   [Full Text] [Related]  

  • 8. HPV vaccination--more answers, more questions.
    Sawaya GF; Smith-McCune K
    N Engl J Med; 2007 May; 356(19):1991-3. PubMed ID: 17494933
    [No Abstract]   [Full Text] [Related]  

  • 9. Human papillomavirus vaccines and vaccine implementation.
    de Sanjosé S; Alemany L; Castellsagué X; Bosch FX
    Womens Health (Lond); 2008 Nov; 4(6):595-604. PubMed ID: 19072462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quadrivalent vaccine for human papillomavirus.
    Brown C; Gaston K
    Drugs Today (Barc); 2006 Nov; 42(11):703-9. PubMed ID: 17171189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current immunization committee includes vaccination against human papillomaviruses in the immunization schedule].
    Kinderkrankenschwester; 2007 May; 26(5):205. PubMed ID: 17550093
    [No Abstract]   [Full Text] [Related]  

  • 12. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?
    Juraskova I; Bari RA; O'Brien MT; McCaffery KJ
    Womens Health Issues; 2011; 21(1):71-9. PubMed ID: 21185992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
    Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
    JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
    Malinova M
    Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study.
    Brisson M; Laprise JF; Drolet M; Van de Velde N; Franco EL; Kliewer EV; Ogilvie G; Deeks SL; Boily MC
    Vaccine; 2013 Aug; 31(37):3863-71. PubMed ID: 23830974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new HPV vaccination.
    Bedford H
    Community Pract; 2008 Aug; 81(8):36-7. PubMed ID: 18834017
    [No Abstract]   [Full Text] [Related]  

  • 18. HPV vaccines to prevent cervical cancer and genital warts: an update.
    Dochez C; Bogers JJ; Verhelst R; Rees H
    Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing an HPV vaccine to prevent cervical cancer and genital warts.
    Bryan JT
    Vaccine; 2007 Apr; 25(16):3001-6. PubMed ID: 17289220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why are anogenital warts diagnoses decreasing in the U.K.: bivalent human papillomavirus (HPV) vaccine cross-protection or failure to examine?
    Clarke E; Board C; Patel N; Atkinson L; Tulloch H; Patel R
    Sex Transm Infect; 2014 Dec; 90(8):587. PubMed ID: 25398729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.